Skip to main content
. Author manuscript; available in PMC: 2012 Jun 21.
Published in final edited form as: J Allergy Clin Immunol. 2009 Jul 16;124(2):238–244.e5. doi: 10.1016/j.jaci.2009.05.014

TABLE II.

Medication status (n = 805)

PR (n = 405) RI-PR (n = 112) RI-DR (n = 137) RI white (n = 151) Post hoc comparisons
Inhaled steroid use (%) 15 48 34 50 PR < RI-DR < RI-PR, RI white*
Any controller medication (%) 32 65 63 68 PR < RI-PR RI-DR, RI white*

PR, Puerto Rican; RI-PR, RI Puerto Rican; RI-DR, RI Dominican; NS, not significant.

*

P < .001.